Literature DB >> 7869614

The possible role of age-related increase in the plasma glucagon/insulin ratio in the enhanced hepatic gluconeogenesis and hyperglycemia in genetically diabetic (C57BL/KsJ-db/db) mice.

H Kodama1, M Fujita, M Yamazaki, I Yamaguchi.   

Abstract

Genetically diabetic db/db mice and their normoglycemic littermates (+/+ mice) were studied to determine plasma levels of glucose, glucagon and insulin and hepatic gluconeogenic enzyme activities. Plasma glucose levels did not differ significantly between the 5-week-old db/db and +/+ mice, but increased with age in the former until the animals were 16-week-old. Similar age-associated changes were observed in the activities of the gluconeogenic enzymes, glucose-6-phosphatase (G-6-Pase) and fructose-1,6-diphosphatase (F-1,6-DPase). While the plasma levels of insulin and glucagon that peaked at 7 weeks of age did not parallel the hyperglycemia, the plasma glucagon/insulin (G/I) ratio roughly paralleled the hyperglycemia. Analysis of individual values for the db/db mice revealed statistically significant (P < 0.001) correlations between plasma glucose levels and hepatic G-6-Pase (r = 0.78) or F-1,6-DPase (r = 0.74) activity. There were also significant correlations between the G/I ratio and plasma glucose levels (P < 0.001, r = 0.66), hepatic G-6-Pase (P < 0.01, r = 0.48) or F-1,6-DPase (P < 0.01, r = 0.57) activity. It is thus concluded that the relative predominance of glucagon over insulin action plays an important role in the age-associated development of hyperglycemia in db/db mice. Glucagon presumably activates the hepatic gluconeogenic enzymes to enhance hepatic glucose output.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7869614     DOI: 10.1254/jjp.66.281

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  4 in total

1.  Mouse Models of Bariatric Surgery.

Authors:  Deng Ping Yin; Kelli L Boyd; Phillip E Williams; Naji N Abumrad; David H Wasserman
Journal:  Curr Protoc Mouse Biol       Date:  2012-12-01

2.  The response of glucose-excited neurones in the ventromedial hypothalamus to decreased glucose is enhanced in a murine model of type 2 diabetes mellitus.

Authors:  V E Cotero; B B Zhang; V H Routh
Journal:  J Neuroendocrinol       Date:  2009-12-04       Impact factor: 3.627

3.  AAV GCG-EGFP, a new tool to identify glucagon-secreting α-cells.

Authors:  Eva Tudurí; Maria M Glavas; Ali Asadi; Robert K Baker; Cara E Ellis; Galina Soukhatcheva; Marjolaine Philit; Frank K Huynh; James D Johnson; C Bruce Verchere; Timothy J Kieffer
Journal:  Sci Rep       Date:  2019-07-25       Impact factor: 4.379

4.  A propolis-derived small molecule ameliorates metabolic syndrome in obese mice by targeting the CREB/CRTC2 transcriptional complex.

Authors:  Yaqiong Chen; Jiang Wang; Yibing Wang; Pengfei Wang; Zan Zhou; Rong Wu; Qian Xu; Hanyun You; Yaxin Liu; Lei Wang; Lingqin Zhou; Yuting Wu; Lihong Hu; Hong Liu; Yi Liu
Journal:  Nat Commun       Date:  2022-01-11       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.